Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

8.570 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 24, 2026 Add to My Watchlist

Price and Volume

Volume	2,476
Open	8.570
Bid (Size)	8.600 (300)
Ask (Size)	8.750 (1,200)
Prev. Close	8.570
Today's Range	8.570 - 8.570
52wk Range	2.960 - 40.37
Shares Outstanding	45,711,975
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) - Lead Plaintiff Deadline is September 28, 2026

September 24, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

September 24, 2026

From SkyMedia, LLC

Via GlobeNewswire

Performance

YTD	-69.7%	-69.7%
1 Month	+3.4%	+3.4%
3 Month	-71.8%	-71.8%
6 Month	-71.4%	-71.4%
1 Year	+38.4%	+38.4%

More News

Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026

September 24, 2026

Via NewMediaWire

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

September 24, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (CAPR)

September 24, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on September 28, 2026 Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)

September 23, 2026

Via NewMediaWire

CAPR 5-DAY DEADLINE: Capricor Investors Have Opportunity to Lead Class Action - HBSS

September 23, 2026

From Hagens Berman

Via Business Wire

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026

September 23, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

September 22, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

CAPRICOR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - CAPR

September 22, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR

September 22, 2026

From Pomerantz LLP

Via GlobeNewswire

Kaplan Fox Continues to Alert Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Class Action Deadline on September 28, 2026

September 22, 2026

Via NewMediaWire

CAPRICOR THERAPEUTICS, INC. (CAPR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline

September 22, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026

September 22, 2026

Via NewMediaWire

Bragar Eagel & Squire, P.C. Urges Capricor Therapeutics, Inc. Investors With Large Losses to Contact the Firm Before the September 28th Deadline

September 21, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026

September 21, 2026

Via NewMediaWire

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

September 21, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to a Securities Fraud Lawsuit – Lead Plaintiff Deadline is September 28, 2026

September 21, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 28, 2026

September 18, 2026

Via NewMediaWire

Kaplan Fox Advises Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) of an Upcoming Securities Class Action Deadline on September 28, 2026

September 18, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm Before Lead Plaintiff Deadline on September 28, 2026

September 17, 2026

Via NewMediaWire

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

September 17, 2026

From SkyMedia, LLC

Via GlobeNewswire

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

September 17, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (CAPR)

September 17, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026

September 17, 2026

Via NewMediaWire

Frequently Asked Questions

Is Capricor Therapeutics, Inc. - Common Stock publicly traded?

Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?

Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?

The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market

What is the current price of Capricor Therapeutics, Inc. - Common Stock?

The current price of Capricor Therapeutics, Inc. - Common Stock is 8.570

When was Capricor Therapeutics, Inc. - Common Stock last traded?

The last trade of Capricor Therapeutics, Inc. - Common Stock was at 09/24/26 04:00 PM ET

What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?

The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 391.75M

How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?

Capricor Therapeutics, Inc. - Common Stock has 392M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.